BIOMAT Database Logo BIOMAT Database Logo

Complement component C3: molecular basis of the C3*S025 variant and evidence for molecular heterogeneity of other variants. 1995

T Höhler, and M Botto, and C Rittner, and P M Schneider, and K H Meyer zum Büschenfelde
I Med Klinik and Poliklinik, Johannes Gutenberg University Mainz, Germany.

Complement component 3 (C3) is the central molecule of the complement system. It displays a number of polymorphic variants with, as yet, unclear functional consequences. We have investigated a number of rare C3 variants by PCR-SSCP (polymerase chain reaction-single strand conformation polymorphism) analysis and could identify the molecular basis of a C3*S025 variant. The decreased electrophoretic mobility of this protein is caused by the exchange of a neutral serine residue to an arginine residue (positively charged). This exchange is unlikely to have functional consequences as it maps to the C-terminus of the alpha-chain. C3 variants appear to have originated from various independent mutations as we could not detect this mutation in different allotypes.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D003176 Complement C3 A glycoprotein that is central in both the classical and the alternative pathway of COMPLEMENT ACTIVATION. C3 can be cleaved into COMPLEMENT C3A and COMPLEMENT C3B, spontaneously at low level or by C3 CONVERTASE at high level. The smaller fragment C3a is an ANAPHYLATOXIN and mediator of local inflammatory process. The larger fragment C3b binds with C3 convertase to form C5 convertase. C3 Complement,C3 Precursor,Complement 3,Complement C3 Precursor,Complement Component 3,Precursor-Complement 3,Pro-C3,Pro-Complement 3,C3 Precursor, Complement,C3, Complement,Complement, C3,Component 3, Complement,Precursor Complement 3,Precursor, C3,Precursor, Complement C3,Pro C3,Pro Complement 3
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA
D016133 Polymerase Chain Reaction In vitro method for producing large amounts of specific DNA or RNA fragments of defined length and sequence from small amounts of short oligonucleotide flanking sequences (primers). The essential steps include thermal denaturation of the double-stranded target molecules, annealing of the primers to their complementary sequences, and extension of the annealed primers by enzymatic synthesis with DNA polymerase. The reaction is efficient, specific, and extremely sensitive. Uses for the reaction include disease diagnosis, detection of difficult-to-isolate pathogens, mutation analysis, genetic testing, DNA sequencing, and analyzing evolutionary relationships. Anchored PCR,Inverse PCR,Nested PCR,PCR,Anchored Polymerase Chain Reaction,Inverse Polymerase Chain Reaction,Nested Polymerase Chain Reaction,PCR, Anchored,PCR, Inverse,PCR, Nested,Polymerase Chain Reactions,Reaction, Polymerase Chain,Reactions, Polymerase Chain
D018740 Genetic Heterogeneity The presence of apparently similar characters for which the genetic evidence indicates that different genes or different genetic mechanisms are involved in different pedigrees. In clinical settings genetic heterogeneity refers to the presence of a variety of genetic defects which cause the same disease, often due to mutations at different loci on the same gene, a finding common to many human diseases including ALZHEIMER DISEASE; CYSTIC FIBROSIS; LIPOPROTEIN LIPASE DEFICIENCY, FAMILIAL; and POLYCYSTIC KIDNEY DISEASES. (Rieger, et al., Glossary of Genetics: Classical and Molecular, 5th ed; Segen, Dictionary of Modern Medicine, 1992) Heterogeneity, Genetic,Genetic Heterogeneities,Heterogeneities, Genetic
D018807 Polymorphism, Single-Stranded Conformational Variation in a population's DNA sequence that is detected by determining alterations in the conformation of denatured DNA fragments. Denatured DNA fragments are allowed to renature under conditions that prevent the formation of double-stranded DNA and allow secondary structure to form in single stranded fragments. These fragments are then run through polyacrylamide gels to detect variations in the secondary structure that is manifested as an alteration in migration through the gels. SSCP,Single-Stranded Conformational Polymorphism,Conformational Polymorphism, Single-Stranded,Conformational Polymorphisms, Single-Stranded,Polymorphism, Single Stranded Conformational,Polymorphisms, Single-Stranded Conformational,Single Stranded Conformational Polymorphism,Single-Stranded Conformational Polymorphisms

Related Publications

T Höhler, and M Botto, and C Rittner, and P M Schneider, and K H Meyer zum Büschenfelde
Molecular basis of polymorphisms of human complement component C3.
October 1990, The Journal of experimental medicine,
T Höhler, and M Botto, and C Rittner, and P M Schneider, and K H Meyer zum Büschenfelde
Human complement component C3: characterization of active C3 S and C3 F, the two common genetic variants.
August 1985, Molecular immunology,
T Höhler, and M Botto, and C Rittner, and P M Schneider, and K H Meyer zum Büschenfelde
Molecular basis of complement C3 deficiency in guinea pigs.
July 1990, The Journal of clinical investigation,
T Höhler, and M Botto, and C Rittner, and P M Schneider, and K H Meyer zum Büschenfelde
[The third component of complement, C3].
November 1999, Nihon rinsho. Japanese journal of clinical medicine,
T Höhler, and M Botto, and C Rittner, and P M Schneider, and K H Meyer zum Büschenfelde
Reference typing report for complement component C3.
January 1998, Experimental and clinical immunogenetics,
T Höhler, and M Botto, and C Rittner, and P M Schneider, and K H Meyer zum Büschenfelde
Statistical Validation of Rare Complement Variants Provides Insights into the Molecular Basis of Atypical Hemolytic Uremic Syndrome and C3 Glomerulopathy.
April 2018, Journal of immunology (Baltimore, Md. : 1950),
T Höhler, and M Botto, and C Rittner, and P M Schneider, and K H Meyer zum Büschenfelde
Conformational complexity of complement component C3.
January 2006, Advances in experimental medicine and biology,
T Höhler, and M Botto, and C Rittner, and P M Schneider, and K H Meyer zum Büschenfelde
Third component of human complement: C3.
January 1990, Methods in enzymology,
T Höhler, and M Botto, and C Rittner, and P M Schneider, and K H Meyer zum Büschenfelde
Engineering of human complement component C3 for catalytic inhibition of complement.
April 2005, Immunology letters,
T Höhler, and M Botto, and C Rittner, and P M Schneider, and K H Meyer zum Büschenfelde
The molecular basis for genetic deficiency of the second component of human complement.
July 1985, The New England journal of medicine,
Copied contents to your clipboard!